Glucose turnover and disposal in maturity-onset diabetes
- PMID: 4750440
- PMCID: PMC302578
- DOI: 10.1172/JCI107502
Glucose turnover and disposal in maturity-onset diabetes
Abstract
The glucose turnover rate in maturity-onset diabetes in man has been variously reported as increased, normal, and decreased. The present experiments suggest that these discrepancies may have been due to methodology, and to nonrecognition of a circadian cycle in the glucose turnover rate that is present in health, and marked in diabetes. During the early morning hours the glucose turnover rate in maturity-onset diabetes is increased in proportion to the fasting blood glucose level. It may reach three to four times the rate found in health. During the evening hours the increments are about one-half as great. The glucose outflow rate constant, k, lower in diabetes than in health, is also lower in both groups in the evening than in the morning. An analysis of the relative contributions of glucose overproduction and underutilization to the development of hyperglycemia in maturity-onset diabetes indicates that overproduction is the greater factor. The relative role of underutilization appears to increase as the fasting blood glucose level increases. The circulating glucose oxidation rate in maturity-onset diabetes is only slightly lower than in health, but the fraction oxidized is markedly lower, and only a small fraction is excreted. The principal conclusion is that in maturity-onset diabetes there is a hypertrophied flux of endogenous glucose, most of which is neither oxidized nor excreted. The precursors and the qualitative and quantitative metabolic fates of this excess glucose are unknown.
Similar articles
-
Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.J Clin Invest. 1979 May;63(5):939-46. doi: 10.1172/JCI109394. J Clin Invest. 1979. Retraction in: Diabetes. 1980 Aug;29(8):672. doi: 10.2337/diab.29.8.672b. PMID: 376552 Free PMC article. Retracted.
-
Metabolic effects of somatostatin in maturity-onset diabetes.N Engl J Med. 1977 Jul 28;297(4):181-3. doi: 10.1056/NEJM197707282970403. N Engl J Med. 1977. PMID: 876274
-
[Glisoxepide treatment in maturity-onset diabetics (author's transl)].Dtsch Med Wochenschr. 1976 Nov 5;101(45):1643-6. doi: 10.1055/s-0028-1104316. Dtsch Med Wochenschr. 1976. PMID: 1033056 Clinical Trial. German.
-
[Early-morning hyperglycemia in patients with diabetes mellitus types 1 and 2].Wiad Lek. 1989 Apr 30;42(8):529-32. Wiad Lek. 1989. PMID: 2697976 Review. Polish.
-
Regulation of glucose storage in obesity and diabetes: metabolic aspects.Diabetes Metab Rev. 1988 Nov;4(7):691-700. doi: 10.1002/dmr.5610040706. Diabetes Metab Rev. 1988. PMID: 3069399 Review. No abstract available.
Cited by
-
The development of hyperglycaemia in patients with insulin-resistant generalized lipoatrophic syndromes.Diabetologia. 1993 Dec;36(12):1288-92. doi: 10.1007/BF00400807. Diabetologia. 1993. PMID: 8307257
-
Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.J Clin Invest. 1984 Mar;73(3):664-72. doi: 10.1172/JCI111258. J Clin Invest. 1984. PMID: 6368585 Free PMC article.
-
Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension.BMJ. 1994 Jul 23;309(6949):226-30. doi: 10.1136/bmj.309.6949.226. BMJ. 1994. PMID: 7818648 Free PMC article. Clinical Trial.
-
The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man.J Clin Invest. 1976 Jul;58(1):7-15. doi: 10.1172/JCI108460. J Clin Invest. 1976. PMID: 6491 Free PMC article.
-
Oxidation of an exogenous glucose load using naturally labelled 13C-glucose. Effect of butylbiguanide therapy in obese mildly diabetic subjects.Diabetologia. 1978 Jan 14;14(1):39-45. doi: 10.1007/BF00429706. Diabetologia. 1978. PMID: 627331
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources